Clinical trial NCT05468151: Cold Acclimation As a Modulator of Brown Adipose Tissue Function in Adults with Obesity
Official title: Cold Acclimation As a Modulator of Brown Adipose Tissue Function in Adults with Obesity
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: Obesity
Lead sponsor: Turku University Hospital
Sponsor class: OTHER_GOV
Collaborators: name: University of Turku
name: University of Barcelona
name: University of Ottawa
First posted: 2022-07-21
Enrollment: 45
Sex: ALL
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This study will investigate the effects of at least 12 weeks of weekly cold water immersions (water temperature 18ºC) on BAT perfusion in individuals with obesity. BAT oxygen uptake and tissue perfusion will be measured using 15O-O2 and 15O-H2O PET-CT, at room temperature and after cold exposure. In addition, BAT glucose uptake will be measured using 18F-FDG after 2 hours of cold exposure and BAT NEFA uptake will be analyzed using 18F-FTHA at room temperature.

To understrand the metabolic effects of BAT activation in individuals with obesity and how the cold water immersions affect the BAT perfusion in humans is critical for the development of new strategies to treat obesity and its comorbidities.

Detailed description: Obesity is a highly prevalent non-communicable disease that effects more than 20% of the population worldwide. Brown adipose tissue (BAT) has an unique ability to dissipate the energy as heat and it has been associated with metabolic benefits. Additionally, BAT has been found to be more active in young, healthy, lean individuals and to be inactive in subjects with obesity. Some studies have shown that repeated cold acclimation can enhance BAT metabolism, which is accompanied by metabolic benefits, such as improvements in insulin sensitivity. In this study we will investigate whether 12 weeks or more of cold acclimation are sufficient to improve BAT perfusion at room temperature and after 2 hours of cold exposure, and to stimulate glucose uptake (measured using 18F-FDG) in BAT after 2 hours of cold exposure. Furthermore, changes in BAT NEFA uptake will be analyzed using 18F-FTHA at room temperature. The metabolic effects of the cold acclimation protocol will be evaluated by changes in classical cardiovascular risk markers (lipid profile, glucose and insulin) after 12 weeks. Two different control groups will be included: one will include lean, healthy participants while the other will include subjects with obesity. Both groups will undergo the BAT PET/scans protocol at room temperature and after cold exposure to investigate BAT perfusion, BAT glucose uptake and BAT NEFA uptake. The volunteers with obesity will also undergo a second evaluation 12 weeks after baseline measurements.

Eligibility criteria: Inclusion Criteria:

* BMI\>30kg/m2 (for participants with obesity)
* BMI\<25kg/m2 (for lean participants)
* Waist circumference \>94 cm for men (for participants with obesity)
* Waist circumference \> 80 for women (for participants with obesity)
* Glucose ≥7.8 and \<11 mmol/L after OGTT (for participants with obesity)

Exclusion Criteria:

* Being regularly exposed to cold environments for the last 3 months (e.g. having a job as a ski monitor, fishmonger, woodcutter, etc.; or doing sports/leisure activities outdoors for prolonged periods of time, etc.)
* Having gone for winter/ice swimming and bathing more than once every 2 weeks during the last 3 months.
* Inability to undergo scanning (e.g., claustrophobia)
* Pregnancy
* Smoking (or use of nicotine based products)
* Hypo/hyperthyroidism
* Malignancies
* Immune disorders
* Viral or bacterial infections
* Abnormal cardiovascular status, arrhythmia and/or long QTc in ECG, abnormal cardiac murmur, previous history of cardiovascular disease
* Allergy to lidocaine or epinephrine, or other local anaesthetics
* Weight change (intentional or not) over the last 6-months \> than 5% of body weight
* Any other cardiovascular, pulmonary, orthopaedic, neurologic, psychiatric or other conditions that in the opinion of the local clinician/researcher, would preclude participation and successful completion of the protocol, or that would negatively impact or mitigate participation in and completion of the protocol.

Primary outcomes:
measure: Brown adipose tissue perfusion
timeFrame: After at least 12 weeks of cold acclimation
Secondary outcomes:
measure: Brown adipose tissue glucose uptake
timeFrame: After at least 12 weeks of cold acclimation
measure: Brown adipose tissue NEFA uptake
timeFrame: After at least 12 weeks of cold acclimation
Other outcomes:
measure: Metabolic parameters
timeFrame: After at least 12 weeks of cold acclimation
measure: Energy expenditure
timeFrame: After at least 12 weeks of cold acclimation
measure: BAT gene expression
timeFrame: After at least 12 weeks of cold acclimation
Locations:
city: Turku
country: Finland
facility: Turku PET Centre
Study officials:
affiliation: Turku University Hospital
name: Kirsi A Virtanen
role: PRINCIPAL_INVESTIGATOR
affiliation: Turku PET Centre
name: Francisco Acosta, PhD
role: STUDY_DIRECTOR
affiliation: Turku PET Centre
name: Mueez U-Din, PhD
role: STUDY_DIRECTOR
References: